ImmunityBio COVID-19 vaccine

The ImmunityBio COVID-19 vaccine, codenamed hAd5, is a non replicating viral vector[1] COVID-19 vaccine developed by the United States-based pharmaceutical company ImmunityBio.[2][1]

ImmunityBio
Vaccine description
TargetSARS-CoV-2
Vaccine typeViral vector
Clinical data
Trade nameshAd5
Identifiers
CAS Number
  1. ^ a b "ImmunityBio Inc: hAd5-Covid-19 – COVID19 Vaccine Tracker". covid19.trackvaccines.org. Retrieved 23 March 2021.
  2. ^ "SA's Biovac to team up with US based ImmunityBio in making its vaccine". BusinessInsider. Retrieved 23 March 2021.